Recent Development of 1,2,4-triazole-containing Compounds as Anticancer Agents

Author:

Wen Xiaoyue1,Zhou Yongqin1,Zeng Junhao1,Liu Xinyue1

Affiliation:

1. The Institute of Infection and Inflammation, China Three Gorges University, Yichang, Hubei 443000, China

Abstract

1,2,4-Triazole derivatives possess promising in vitro and in vivo anticancer activity, and many anticancer agents such as fluconazole, tebuconazole, triadimefon, and ribavirin bear a 1,2,4-triazole moiety, revealing their potential in the development of novel anticancer agents. This review emphasizes the recent advances in 1,2,4-triazole-containing compounds with anticancer potential, and the structureactivity relationships as well as mechanisms of action are also discussed.

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,General Medicine

Reference144 articles.

1. Latest global cancer data: Cancer burden rises to 18.1 million new cases and 9.6 million cancer deaths in 2018. Available From (Accessed 2018).

2. American Association for Cancer Research. Cancer progress report Available From (Accessed 2019).2019

3. Mansoori B.; Mohammadi A.; Davudian S.; Shirjang S.; Baradaran B.; The different mechanisms of cancer drug resistance: A brief review. Adv Pharm Bull 2017,7(3),339-348

4. Gottesman M.M.; Mechanisms of cancer drug resistance. Annu Rev Med 2002,53,615-627

5. Gao F.; Wang T.; Xiao J.; Huang G.; Antibacterial activity study of 1,2,4-triazole derivatives. Eur J Med Chem 2019,173,274-281

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3